Aqemia
FranceEntry
2024
Hold
2yr
Status
Active
Who owns Aqemia?
Aqemia is currently owned by Cathay Capital through Cathay Innovation Fund III (2024 vintage), since 2024. Across its history, Aqemia has been through 5 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Cathay CapitalCathay Innovation Fund III · 2024 · VC
5 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Elaia Partners, Lazard Elaia Capital, Eurazeo, Wendel and Cathay Capital since 2019.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
Active
Co-invest · 5 holders · 2019 · present
Elaia PartnersActive
2019 · present(7yr) · PSL Innovation Fund · 2018 · VC
EurazeoActive
2020 · present(6yr) · Idinvest Digital Fund III · 2018 · VC
Lazard Elaia CapitalActive
2020 · present(6yr) · Elaia Legacy Fund · 2002 · VC
WendelActive
2023 · present(3yr) · Wendel Growth · 2023 · Growth
Cathay CapitalActive
2024 · present(2yr) · Cathay Innovation Fund III · 2024 · VC
More from Cathay Innovation Fund III
Other portfolio companies in the same fund.
US
SpainMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Track Aqemia
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Aqemia?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Aqemia.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue